Cole W. Peters

This paper develops a PAX3-FOXO1-targeted oncolytic herpes virus that improves tumor control in immunocompetent mouse models when combined with anti-PD1 therapy.

This study delivers GJB2 specifically to target cells in mouse models of DFNB1 deafness, restoring hearing function and validating the approach in nonhuman primates.

This paper demonstrates a dual-AAV gene therapy strategy for USH1F, restoring hearing, balance, and retinal function in mouse and human models.

quasitools provides open-source tools for analyzing viral quasispecies data, including consensus sequence creation, variant calling, complexity calculation, and genetic distance measurement.